Shinsegae, Hana Financial, Bain Capital to finance $438 mn Starfield Cheongna

Shinsegae Property, a subsidiary of South Korean retail giant Shinsegae Group, on Tuesday unveiled a 600 billion won ($438 million) investment agree...
Shinsegae Property, a subsidiary of South Korean retail giant Shinsegae Group, on Tuesday unveiled a 600 billion won ($438 million) investment agree...
Hana Asset Management Co. will list the “1Q US Nasdaq 100 ETF” on Tuesday, an exchange-traded fund that tracks the Nasdaq 100 index with...
BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...
Lotte Chemical Corp. and HD Hyundai Co. are in talks to consolidate their naphtha cracking operations in South Korea’s Daesan petrochemical co...
Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufac...
Samsung Group’s financial affiliates are closing in on KB Financial Group for the top spot in South Korea’s financial services sector, u...
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...
The South Korean defense industry's current heyday is expected to continue for a while as global demand for Korean-made weapons and combat systems h...
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...
Doosan Enerbility Co., South Korea’s leading gas turbine maunfacturer for power plants, said on Thursday that it has secured a combined $1.5 b...
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...
South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...
South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...
South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...
South Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...
IMM Investment, Korea Investment Private Equity (PE), Corstone Asia, and Paratus Investment have been selected for the Export-Import Bank of Korea's...
Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...
South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
Korea Electric Power Corp. (KEPCO), the South Korean state-run utility company, said on Thursday it signed a memorandum of understanding (MOU) with ...
Solus Advanced Materials, a South Korean copper foil supplier, said on Tuesday it started mass production at its second plant in Hungary, Europe&rsq...
South Korea's LG Uplus Corp. said on Wednesday the release of its "6G White Paper: Non-Terrestrial Networks," which explores the future direction of...